Geneoscopy's Erica Barnell on AI in Gastrointestinal Health Diagnostics

Erica Barnell is the co-founder and Chief Science Officer at Geneoscopy Inc., a clinical-stage diagnostic company working on early detection of colorectal cancer. Its technology analyzes RNA in stool samples to look for early warning signs of cancer, providing a non-invasive alternative to colonoscopies. Geneoscopy raised a $6.9m Series A in 2019; in 2020, its diagnostic device was awarded Breakthrough Device Designation from the FDA and Erica was listed in Forbes 30 Under 30, and in 2021 a p...